Please login to the form below

Not currently logged in
Email:
Password:

lung disease

This page shows the latest lung disease news and features for those working in and with pharma, biotech and healthcare.

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

According to the company, the potential first-in-class treatment was able to achieve complete blockage of viral replication in an in vitro model of human lung bronchial tissues. ... benefit COVID-19 patients by inhibiting the key drivers of disease

Latest news

More from news
Approximately 4 fully matching, plus 111 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    complications of disease whether measured symptomatically, radiographically, and increasingly with novel measurement techniques. ... endpoints that can better characterise the benefit of new drugs for early disease.

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    The lexicon of lung disease has been developing over four centuries from its early livid descriptions such as turgid, voluminous and catarrh coined by physicians navigating various airflow restrictions now known ... COPD was a Cinderella disease when I

  • #OrkambiNow? #OrkambiNow?

    People with this genetically inherited disease are vulnerable to potentially deadly lung infections, and currently half the people in the UK with CF die before the age of 31. ... died from the disease who might have lived had they received the drug.

  • Significant figures Significant figures

    ALIS (Amikacin liposome inhalation suspension) is being developed as a treatment for refractory non tuberculous Mycobacterial (NTM) lung disease, a rare progressive, destructive infection caused by mycobacterium avium complex. ... However, Insmed

  • Pharma deals during August 2014 Pharma deals during August 2014

    It also has potential utility in treating systemic sclerosis-related Interstitial Lung Disease. ... This should reduce procedure time and stimulation-induced side effects and has utility in conditions such as Parkinson's disease and essential tremor.

More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics